MEDLIOR offers high-quality and cost-effective support for health technology assessment (HTA) submissions in Canada and the UK.
For Canadian submissions, MEDLIOR’s expertise includes development of the economic and clinical components required for public and private plans, as well as preparation and distribution of the submission packages to payers across Canada.
Our team is experienced with preparing submissions for the Canadian Agency for Drugs and Technologies in Canada (CADTH) Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR), with services that include:
For our UK clients, MEDLIOR works with our Strategic Partners to prepare submissions for the National Institute for Health and Care Excellence (NICE) and the Scottish Medicines Consortium (SMC), with services that include:
Our client-focused project management ensures that the quality and rigor of the submission package is tailored to the needs of your submission.